We&Win Diversification Co Ltd (4113.TWO) stock: key figures, P/E, revenue and dividend
Industrials · Construction & Engineering · Taiwan · ISIN TW0004113006
We&Win Diversification Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 5.72 bn TWD | 610.18 m TWD |
| Gross profit | 1.52 bn TWD | 125.12 m TWD |
| Operating income | 1.04 bn TWD | -2.54 m TWD |
| EBIT | 1.06 bn TWD | 24.28 m TWD |
| Net income | 770.81 m TWD | -100.03 m TWD |
| Diluted EPS – continuing operations | 3.33 TWD | -0.43 TWD |
Full history since 2017, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About We&Win Diversification Co Ltd
We & Win Diversification Co., Ltd. engages in the rental and sale of real estate properties in Taiwan. It is also involved in the public facilities construction investment; new towns and community development; wholesale of medical equipment; and international trade businesses. The company was formerly known as Oncoprobe Biotech Inc. and changed its name to We & Win Diversification Co., Ltd. in 2009. We & Win Diversification Co., Ltd. was founded in 1987 and is based in Kaohsiung, Taiwan.
More stocks
- Halmont Properties Corporation (HMT.V)
- AnaPass Inc (123860.KQ)
- Orthex Oyj (ORTHEX.HE)
- Aluko Co Ltd (001780.KS)
- Palomino Laboratories Inc. (PALX)
- Sagittarius Life Science (3205.TWO)
- MSC Co. Ltd (009780.KQ)
- Leo Systems (5410.TWO)
- QDM International Inc. (QDMI)
- DATA MODUL Aktiengesellschaft Produktion und Vertrieb von elektronischen Systemen (DAM.DE)
- Polaryx Therapeutics, Inc. (PLYX)
- Webjet Group Ltd (WJL.AX)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.